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A B S T R A C T   
Multimorbidity is an emerging public health priority. This study aims to assess the role of lifestyle and socio-
economic status in the prevalence of multimorbidity and chronic diseases by using two language groups that are 
part of the same genetic subgroup but differ by daily habits. We conducted a cross-sectional survey in 2016 with 
randomly selected population sample with 4173 responders (52.3%) aged 20–69 years in Western Finland. We 
included 3864 Finnish participants with Swedish (28.1%) or Finnish (71.9%) as a native language. We used a 
questionnaire to assess participants’ chronic diseases and lifestyle. We determined multimorbidity as a disease 
count ≥ 2. 
Finnish speakers were more likely to have a diagnosis of COPD, heart failure, diabetes, reflux disease, chronic 
kidney failure, and painful conditions than Swedish speakers. The prevalence of multimorbidity was higher for 
Finnish speakers in the age group of 60–69 years (41.0% vs. 32.0%, p = 0.018) than Swedish speakers. A higher 
proportion of Finnish speakers smoked, were obese, inactive, and had lower socioeconomic status compared to 
Swedish speakers. All these factors, in addition to age and female sex, were significant risk factors for multi-
morbidity. Prevalence of multimorbidity was different in two language groups living in the same area and was 
associated with differences in lifestyle factors such as smoking, physical inactivity and obesity.   
1. Introduction 
Multimorbidity, defined as patients living with two or more chronic 
health conditions, is of paramount public health concern to any aging 
population as the prevalence of multimorbidity increases with age 
(Barnett et al., 2012). The prevalence of multimorbidity seems to be 
increasing, at least in western countries (Buttorff et al., 2017; Leb-
enbaum et al., 2018). 
To understand multimorbidity in a broader context, not only the 
inter-correlation between different diseases or their medication but also 
factors related to the daily life need to be considered (Violan et al., 
2014a). Many prevalence studies on multimorbidity are register-based 
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with limited information on participants’ lifestyle and BMI. One 
approach to overcome this problem is to compare multimorbidity be-
tween countries, in different nationalities or ethnic groups, known to 
have differing habits (Garin et al., 2016). However, this kind of analysis 
may be hampered by geographical factors, different political systems, 
healthcare organizations, and access to healthcare between ethnic 
groups. 
Another way of solving this could be to study two genetically similar 
populations living in the same socio-cultural landscape. Western Finland 
is one of the most affluent areas in the country, which contributes to the 
health benefits in Western Finland when compared to the general pop-
ulation of Finland (Saarela and Finnäs, 2011). Finnish and Swedish 
speaking Finns are part of the same Finnish genetic subpopulation 
(Kerminen et al., 2017), living in the same geographical area sharing the 
same educational institutions and healthcare system but with differing 
daily habits. 
Swedish speakers have less harmful drinking patterns (Paljarvi et al., 
2009), lower rates of sickness allowance, less early retirement (Reini and 
Saarela, 2017; Saarela and Finnäs, 2002), and mortality (Saarela and 
Finnäs, 2011, 2005). The mortality difference between language-groups 
is highest in deaths related to alcohol, suicide, and other external causes 
(Sipilä and Martikainen, 2010). 
Compared to existing studies on socioeconomic inequalities (Ahmadi 
et al., 2016; Mathur et al., 2011), FinEsS Western Finland study popu-
lation provides a different aspect as inequalities concern the majority in 
a population sharing several determinants of health but differing in 
lifestyle. Also, habits were asked from the study participants, instead of 
making assumptions based on how the different language groups differ 
on average. The aim was to assess prevalence of multimorbidity in 
Swedish and Finnish speaking people in Western Finland and to evaluate 
lifestyle factors associated with multimorbidity. 
2. Methods 
2.1. Study design and participants 
In collaboration with Nordic EpiLung, the latest FinEsS’ (Finland- 
Estonia-Sweden) survey for Western Finland was conducted in February 
2016. Health questionnaires were sent to 8,000 randomly selected re-
cipients aged 20–69 years in hospital districts of South Ostrobothnia and 
Vaasa. We identified recipients’ personal information from the Finnish 
Population Register, and the sample reflected the population in the 
study area. The official native language of a recipient determined 
whether we used a Finnish or Swedish questionnaire. We sent two re-
minders to those not responding. 
2.2. Compliance with ethical standards 
Ethics Committee of the Department of Medicine of Helsinki Uni-
versity Central Hospital approved the study (approval number 200/13/ 
03/00/15). Informed written consent was obtained from all individual 
participants included in the study. We followed the General Data Pro-
tection Regulation (EU) 2016/679. Patients or the public were not 
involved in the design, or conduct, or reporting, or dissemination plans 
of our research. 
2.3. Questionnaire 
The FinEsS questionnaire comprises questions on respiratory symp-
toms, respiratory diseases, diseases and morbidity in general, risk fac-
tors, occupation, and use of medication, and have previously been used 
in many studies in several countries (Honkamäki et al., 2019; Larsson 
et al., 2003; Pallasaho et al., 2011). 
2.4. Variables 
The assessment of multimorbidity was based on self-reported dis-
eases or medical conditions and defined as disease count ≥ 2 in any 
individual responder (Valderas et al., 2009). The rationale for diseases 
included was based on three independent sources: (1) previous publi-
cation (Barnett et al., 2012), (2) the most common comorbidities found 
in adult asthma in the same area (Ilmarinen et al., 2016), and (3) 
comorbidities reported to be associated with asthma (Kankaanranta 
et al., 2016). 
The question asked on diseases was ’Has a doctor diagnosed you with 
any one of the following diseases: asthma, chronic obstructive pulmo-
nary disease (COPD), hypertension, coronary heart disease, atrial 
fibrillation or another cardiac arrhythmia, heart failure, stroke or tran-
sient ischemic attack, diabetes, depression, panic attack or anxiety, 
treated dyspepsia/reflux disease, chronic kidney failure, sleep apnea, 
osteoporosis, and painful condition requiring daily analgesic medica-
tion?’ with tick boxes yes/no for each of the diseases. 
Participants were considered to be physically active if they were 
physically active at least three hours (≥180 min) per day, which was 
answered by the question ’How many hours in a day do you spend 
moving/physically active?’. We divided participants into current 
smokers, ex-smokers (when the participants stopped smoking more than 
12 months before), and never smokers (neither a current smoker nor an 
ex-smoker). Body Mass Index (BMI) was based on self-reported height 
and weight and was categorized as follows: under and normal weight <
25 kg/m2, overweight 25.0–29.9 kg/m2, obesity grade I 30.0–34.9 kg/ 
m2 and obesity grade II ≥ 35.0 kg/m2. 
We asked each participant of their main occupation. Occupations 
were classified according to The International Standard Classification of 
Occupations 2008 (ISCO-08), providing a system for classifying pro-
fessional skill levels in a four-level hierarchy. ISCO-08 skill level 1 is the 
primary level of education, and level 4 is higher education (Gaskin et al., 
2014). Occupational exposure to vapors, gases, dust, or fumes (VGDF) 
was asked with a question. ’Are you now, or have you been heavily 
exposed to gases, dust, or fumes at work’? 
2.5. Statistical analysis 
Statistical analyses were performed by using IBM SPSS Statistics 
software version 26 (IBM SPSS, Armonk, NY, USA). Pearson chi-square 
–test was used for categorical variables. A p-value < 0.05 was considered 
significant. 
Binary logistic regression models with multimorbidity as outcome 
were performed to calculate unadjusted Odds Ratios (OR) with 95% 
confidence intervals (CI) for age, sex, smoking status, BMI, physical 
activity, skill level, and native language. Multivariable binary logistic 
regression with multimorbidity as outcome was performed to calculate 
adjusted ORs with 95% CI including age, sex, smoking status, BMI, 
physical activity, skill level, and native language in the same model. 
Sensitivity analyses were performed with three different disease 
grouping models (see Appendix). 
3. Results 
3.1. Characteristics of the study participants 
In total, 4173 participants of the 8000 invited responded, yielding a 
participation rate of 52.3%. Of the responders, 206 were excluded due to 
missing data on smoking, and 103 were excluded since their native 
language was not Finnish or Swedish. Altogether 3864 participants were 
included in the present study population (48.3%), of which 2780 
(71.9%) were Finnish speaking, and 1084 (28.1%) were Swedish 
speaking. Fig. A1 shows a flow chart of the study. 
The response rate was 51.4% (2932 out of 5704) for Finnish speakers 
and 60.0% (1132 out of 1886) for Swedish speakers. Non-responders 
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were more often males and younger than responders (Table A1). The 
Finnish speaking group aged 20–39 years is most underrepresented. The 
age group 60–69 years has response rate of 73.8% (72.1% for Finnish 
speakers and 78.8% for Swedish speakers). For those over 40 years, the 
response rate was 61.7%. 
Table 1 shows characteristics of the study participants. We observed 
a slight dominance of women over men in both language groups. The 
proportion of participants in the youngest age group was higher among 
Swedish speakers than Finnish speakers. The prevalence of obesity, 
active smoking and ex-smoking were higher in Finnish speakers than 
Swedish speakers. The level of physical activity was lower in Finnish 
speakers than Swedish speakers. Also, the ISCO-08 skill level was lower 
in Finnish speakers compared to Swedish speakers, whereas occupa-
tional exposure to VGDF was higher in Finnish speakers than Swedish 
speakers. Prevalence of family history of chronic bronchitis, COPD, or 
emphysema was higher in Finnish speakers than Swedish speakers. 
3.2. Multimorbidity 
Finnish speakers were more likely multi-morbid compared to 
Swedish speakers, with 26.0% prevalence of multimorbidity for Finnish 
speakers and 22.3% for Swedish speakers (p = 0.049). At the level of 
single diseases, Finnish speakers had more frequently a diagnosis of 
COPD (3.0% vs 1.3%, p = 0.002), heart failure (1.7% vs 0.5%, p =
0.002), diabetes (8.1% vs 5.1%, p = 0.001), treated dyspepsia/reflux 
disease (7.2% vs 4.9%, p = 0.008), chronic kidney failure (0.9% vs 0.2%, 
p = 0.016) and painful conditions (9.8% vs 5.1%, p < 0.001) compared 
to Swedish speakers (Table 2). 
3.3. Multimorbidity in different age groups 
There was no significant difference in multimorbidity between 
Finnish and Swedish speakers in age groups 20–39 years (8.9% vs. 
12.1%, p = 0.202) or 40–59 years (22.6% vs. 20.4%, p = 0.427). 
However, in the age group 60–69 years, Finnish speakers were more 
often multimorbid (41.0% vs. 32.0%, p = 0.018) (Fig. A2). 
In the whole study population, the percentage of persons suffering 
from at least 1, 2, 3, or 4 diseases, as well as the morbidity count, 
increased with age (Fig. 1a). The percentage of respondents with at least 
1, 2, 3, or 4 diseases seemed to be higher in Finnish speakers than 
Swedish speakers in older age groups (Fig. 1b). 
3.4. Risk factors for multimorbidity 
Significant independent risk factors for multimorbidity in both un-
adjusted and adjusted analyses were age, current and ex-smoking and 
overweight and obesity (Table 3). Swedish language was a risk-reducing 
factor for multimorbidity only in unadjusted model. Lower skill levels 1 
and 2 were risk factors for multimorbidity only in unadjusted model. 
Physical inactivity was significant risk factor in adjusted model. Age 
over 60 (OR = 5.91) and obesity grade II (OR = 5.62) were the most 
significant risk factors for multimorbidity. 
3.5. Multimorbidity prevalence in association to smoking status, physical 
activity, and BMI 
Since current and ex-smoking, overweight, obesity and physical 
inactivity were significant risk factors for multimorbidity, we calculated 
the prevalence of multimorbidity in association with smoking status, 
physical activity, and BMI. 
Ex-smokers had the highest multimorbidity prevalence in all BMI 
groups (Table A2). Table A3 shows that among obese participants, the 
prevalence of multimorbidity was higher in the physically inactive 
group compared to the physically active group. We had all data on the 
four variables for 3525 out of 3864 participants. We divided participants 
into four groups: never smokers with daily physical activity ≥ 3 h (n =
968), never smokers with daily physical activity < 3 h (n = 916), current 
or ex-smokers with daily physical activity ≥ 3 h (n = 1017), and current 
or ex-smokers with daily physical activity < 3 h (n = 676) and calculated 
multimorbidity prevalence in BMI groups: under and normal weight <
25 kg/m2, overweight 25.0–29.9 kg/m2, obesity grade I 30.0–34.9 kg/ 
m2 and obesity grade II ≥ 35.0 kg/m2. The results are shown in 
Table A4. In the group with BMI < 25 kg/m2, never smokers and 
physically active responders, the prevalence of multimorbidity was 
12.2% and in the group with BMI ≥ 35.0 kg/m2, current or ex-smokers 
Table 1 
Characteristics of the study participants.   
Finnish 
speakers 
n = 2780 
Swedish 
speakers 











918 (34.3%)  
430 (41.3%) 
293 (28.1%) 
319 (30.6%)  
<0.001 
BMI < 25 
BMI 25–29.99 
BMI 30–34.99 






















637 (58.8%)  
<0.001 













162 (18.1%)  
0.008 
Occupational exposure to VGDF 1105 
(40.8%) 
290 (29.4%)  <0.001 
Family history of chronic bronchitis, 
COPD or emphysema 
342 (12.3%) 71 (6.5%)  <0.001 




676 (67.6%)  <0.001 
Data is shown as n (%). Abbreviations: BMI (Body Mass Index), ISCO (Interna-
tional Standard Classification of Occupations), VGDF (Vapors, gases, dust and 
fumes), and COPD (Chronic obstructive pulmonary disease). Missing cases BMI 
82 (2%), physical activity 287 (7%), and skill level 615 (16%) of total 3864. 
Table 2 






Asthma 319 (11.5%) 125 (11.5%)  0.955 
COPD 83 (3.0%) 14 (1.3%)  0.002 
Hypertension 634 (22.8%) 253 (23.3%)  0.733 
Coronary heart disease 84 (3.0%) 29 (2.7%)  0.597 
Atrial fibrillation and other cardiac 
arrhythmias 
215 (7.7%) 70 (6.5%)  0.193 
Heart failure 47 (1.7%) 5 (0.5%)  0.002 
Stroke and transient ischemic attack 61 (2.2%) 29 (2.7%)  0.406 
Diabetes 224 (8.1%) 55 (5.1%)  0.001 
Depression 278 (10%) 101 (9.3%)  0.548 
Panic attack or anxiety 160 (5.8%) 69 (6.4%)  0.495 
Treated dyspepsia, reflux disease 201 (7.2%) 53 (4.9%)  0.008 
Chronic kidney failure 25 (0.9%) 2 (0.2%)  0.016 
Sleep apnea 139 (5.0%) 50 (4.6%)  0.678 
Osteoporosis 75 (2.7%) 24 (2.2%)  0.429 
Painful condition 272 (9.8%) 55 (5.1%)  <0.001 
Data is shown as n (%). 
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and physically inactive participants the prevalence of multimorbidity 
was 57.4%. Results modified for patient education are shown in the 
multimorbidity risk assessment chart in Fig. 2. 
3.6. Sensitivity analyses 
We constructed disease groups to take into account the possible in-
terrelationships between diseases. The three models composed are 
described in Appendix. The difference in multimorbidity prevalence 
between language groups remained after accounting one disease group 
as one disease (Table A5). In multivariable binary logistic regression 
analysis, results remained similar, except physical inactivity lost sig-
nificance (Table A6). 
4. Discussion 
In this study, we found that multimorbidity was more prevalent in 
Finnish speakers compared to Swedish speakers in Western Finland. 
Finnish speakers had a higher BMI, they smoked more often, had a lower 
social status based on occupation, and were physically less active when 
compared to Swedish speakers. These lifestyle-related and socioeco-
nomic aspects were associated with multimorbidity and might explain 
the difference between the two language groups. Finnish speakers had 
significantly more often 6 out of 16 self-reported diagnoses, and they 
had more often a diagnosis of COPD, heart failure, diabetes, treated 
dyspepsia/reflux disease, chronic kidney failure, and painful condition. 
The disease count ≥ 2 is a simple and widely accepted concept to 
define multimorbidity, but it has limitations; it does not consider disease 
severity or inter-relationships. For example, hypertension, and diabetes 
interrelate to cardiovascular disease along with lifestyle-associated 
factors (Straus et al., 2002; Yusuf et al., 2004). Risk factors can be 
associated, or there may be true causality, both options lead to disease 
clusters. Therefore, causal models of multimorbidity should be inter-
preted with high caution (Valderas et al., 2009). Considering the 
possible disease interrelations, we carried out three sensitivity analyses 
with disease grouping based on disease co-occurrence in our cohort and 
the difference between langue groups remained. 
The prevalence of multimorbidity in this study was 26% for Finnish 
speakers and 22% for Swedish speakers, similar to the prevalence in the 
UK (23%) (Barnett et al., 2012), but lower than overall pooled multi-
morbidity prevalence (33%) in a recent literature review (Nguyen et al., 
2019). In Sweden, 38% were multimorbid in the age group 60–74 years 
(Marengoni et al., 2016), compared to 41% vs. 32% in our Finnish and 
Swedish speaking Finns in the age group 60–69 years. 
In a previous study, multimorbidity occurred in deprived areas 
10–15 years earlier than in the most affluent areas (Mercer and Watt, 
2007). In our study, low socioeconomic status had a relationship with 
multimorbidity consistent with current evidence (Donovan et al., 1996; 
Marmot, 2005; Salisbury et al., 2011; Van den Akker et al., 1998; Violan 
et al., 2014b; Walker, 2007). According to our results, Finnish speakers 
with lower socioeconomic status might have poorer health and health 
behaviors. Earlier studies showed that better psychosocial living con-
ditions in childhood and working conditions in adulthood among 
Fig. 1. Prevalence of participants with at least 1, 2, 3 or 4 diseases according to age in the whole study sample (A) and separately in Finnish and Swedish 
speakers (B). 
Table 3 
Factors associated with multimorbidity (morbidity count ≥ 2) in univariate and 
multivariate logistic regression analyses.   
Crude 
OR (95% CI) 
*Adjusted 
OR (95% CI) 
Age groups (20–39 yrs. ref group)   
40–59 yrs. 2.55 (2.01–3.24) 2.35 (1.74–3.16) 
60–69 yrs. 5.85 (4.65–7.37) 5.91 (4.40–7.93) 
Female 1.03 (0.89–1.19) 1.32 (1.09–1.60) 
Swedish-speaking 0.82 (0.69–0.96) 1.13 (0.92–1.40) 
Smoking status (never smoker ref group)   
Current smoker 1.55 (1.28–1.88) 1.85 (1.43–2.38) 
Ex-smoker 2.09 (1.77–2.48) 1.82 (1.47–2.25) 
BMI (<25 ref group)   
Overweight (25–29.9) 1.90 (1.58–2.29) 1.53 (1.23–1.91) 
Obesity grade I (30–34.99) 3.55 (2.85–4.42) 2.73 (2.09–3.56) 
Obesity grade II (≥35-) 7.20 (5.33–9.73) 5.62 (3.88–8.15) 
Duration of daily physical activity < 3 h 1.15 (0.99–1.35) 1.23 (1.01–1.49) 
ISCO-08 Skill level (4 ref group)   
1 1.94 (1.29–2.90) 1.58 (1.00–2.51) 
2 1.59 (1.24–2.04) 1.24 (0.93–1.65) 
3 0.94 (0.75–1.36) 0.98 (0.71–1.36)  
* Adjusted for age, sex, native language, smoking status, BMI, physical ac-
tivity, and skill level. Bold indicates p < 0.05. Abbreviations: BMI (Body Mass 
Index) and ISCO (International Standard Classification of Occupations). 
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Swedish speakers facilitates advanced individual’s sense of coherence 
(Volanen et al., 2006). Sense of coherence is an individual’s capacity to 
manage stress and sustain healthy habits and is related to health in 
general (Eriksson and Lindström, 2005) which may contribute to the 
difference seen in multimorbidity between Swedish and Finnish 
speakers. Social participation is considered to be related to good self- 
rated health and social capita among Swedish speaking Finns (Hyyppä 
and Mäki, 2001, 2003). 
Few previous studies have shown a higher prevalence of multi-
morbidity among minority ethnic populations in East London and Iran 
(Ahmadi et al., 2016; Mathur et al., 2011). However, we describe these 
health disparities in the majority population and with fewer confound-
ing factors, like ethnicity, access to education or healthcare, than in 
previous studies. 
We found that multimorbidity is positively associated with obesity. 
Previously in a longitudinal study in Canada, the most considerable 
increase in multimorbidity was found among seniors living with obesity 
(Lebenbaum et al., 2018). Multimorbidity was highly associated with 
increasing BMI and OR 2.73 for obesity grade I was higher than 
previously reported OR 1.65–2.20 (Agborsangaya et al., 2012; Booth 
et al., 2014). In our study, obesity grade II (OR 5.62) and age of 60–69 
years (OR 5.91) were equal risk factors for multimorbidity. Therefore, 
obesity is the most influential treatable risk factor for multimorbidity. 
Our study shows that physical inactivity defined as daily activity/ 
movement less than three hours a day is a risk factor for multimorbidity. 
The association between physical inactivity was in line with existing 
evidence (Ahmadi et al., 2016; Keats et al., 2017; Wikström et al., 2015), 
although the definition of physical inactivity varies between studies. In 
the Iranian cohort (Ahmadi et al., 2016), physical activity was defined 
only based on occupational activity. The Finnish FINRISK study 
(Wikström et al., 2015) used a complex Physical Activity Questionnaire 
combined with a smaller cohort with activity measurements. A previous 
study used a cut-point of four hours daily to evaluate the association 
between physical inactivity and lung function decline in adult-onset 
asthma (Loponen et al., 2018). Paradoxically, Finnish speaking school-
children aged 14–15 showed more leisure-time exercise despite higher 
amount of alcohol consumption, smoking, and physician-diagnosed 
diseases than Swedish speakers in Western Finland (Saarela and 
Fig. 2. Multimorbidity risk assessment chart.  
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Finnäs, 2004). How regular exercise and physical activity relate to other 
health behaviors needs further studies. 
COPD prevalence has been shown to be higher in minorities and 
among people with low socioeconomic status due to differences in 
health behaviors, mainly smoking, and differences in occupational 
exposure to inhalant toxins. Low socioeconomic status is also associated 
with worsened COPD health outcomes (Axelsson et al., 2018; Dransfield 
and Bailey, 2006; Holt et al., 2011; Pleasants et al., 2016; Tran et al., 
2011). In our study, the Finnish speaking majority had lower socio-
economic status and, hence, more smoking and occupational exposure 
to VGDF. Finnish speakers had two times as frequently diagnosis of 
COPD compared to Swedish speakers. A family history of COPD was 
more common among Finnish speakers than Swedish speakers, pre-
sumably due to family’s habits and occupation. 
We identified ex-smokers as having a higher probability for multi-
morbidity than current smokers, similar to a study in the UK (Booth 
et al., 2014). In contrast to our study, an Australian study showed that 
current smokers had a higher probability for multimorbidity; in sub- 
analyses in the age group >60 years, however, ex-smoking was a 
higher risk for multimorbidity than current smoking (Taylor et al., 
2010). By the age of 60 years, diseases associated with smoking are 
possible, and hence people stop smoking. In a cohort of adult-onset 
asthma, multimorbidity increased dose-dependently with smoked 
pack-years (Tommola et al., 2019), and in that study, the risk for mul-
timorbidity was rather associated with pack-years than with current 
smoking status. We do not have information on smoked pack-years for 
the responders, and we do not know if ex-smokers had more pack-years 
than current smokers. Also, other possible explanations exist. Firstly, 
healthcare integrates interventions to stop smoking into care, and there 
is contact with healthcare at the time of diagnosis. Secondly, smoking 
cessation is associated with weight gain, and paradoxically might 
worsen glycemic control and increase the risk for diabetes, even though 
smoking is a risk factor for diabetes (Bush et al., 2016). Regardless of 
smoking cessation being associated with short-term risk of type 2 dia-
betes, there is still a benefit on cardiovascular and all-cause mortality 
(Hu et al., 2018). 
Overall, studies on multimorbidity combining information on 
obesity, smoking status, and physical activity are rare, and therefore 
findings of our study provide further evidence on the association be-
tween obesity and multimorbidity. The prevalence of multimorbidity 
was 12% in physically active, never smoking participants with normal 
weight and 57% in physically inactive, smoking participants with BMI 
≥ 35.0 kg/m2. Our results demonstrate the phenomenon in a motivating 
way, and the multimorbidity risk assessment chart might be important 
for patient education within smoking cessation, diabetes, and weight 
reduction. 
The major strengths of this study are; random sample, a large sample 
size, and established structured questionnaire. This study was based on 
self-report data, which could be considered as a limitation of this study. 
Another limitation is the lack of knowledge on the disease severity. 
However, the FinEsS questionnaire has been validated in several pre-
vious Nordic studies, and as a large-scale questionnaire, it has several 
benefits compared to register-based data. The self-reported data is 
valuable as it combines information like smoking, exercise, and BMI not 
readily available in register-based data. As another limitation of the 
study, nutritional factors and alcohol consumption were not included in 
the questionnaire. However, we can assume Swedish speakers have a 
healthier diet and more moderate alcohol consumption based on two 
earlier studies (De Oliveira Figueiredo et al., 2019; Paljarvi et al., 2009). 
Disease count did not include information on malignancies and HIV, 
thus the Charlson Comorbidity Index or the ACG System measures could 
not be calculated. Finland is a low HIV prevalence country. Disease 
counts perform as well as sophisticated measures in predicting the 
outcome (Huntley et al., 2012). Due to the lack of standardization of 
diseases included in multimorbidity studies, comparison between 
studies is challenging (Garin et al., 2016; Marengoni et al., 2011). 
The response rate was moderate in the present study. In our study, 
non-responders were younger and more often males compared to re-
sponders, consistent with previous findings (Rönmark et al., 2009). The 
participation rate was higher for Swedish speakers, similar to the FIN-
RISK Study 2012 (Tolonen et al., 2018). However, to minimize bias, we 
used age groups in statistical analysis. We conclude that this study might 
have included some non-responder bias that mainly affects younger and 
males; still, as the main difference in multimorbidity was found in older 
age groups and their response rate was higher, we consider the main 
results to be reliable. 
Taken together, we have shown that smoking, overweight, obesity, 
and physical inactivity were associated with multimorbidity. To reduce 
the disease-burden the general population as well as the specific target 
groups need more information about these findings. Therefore, we 
provided a multimorbidity risk assessment chart for patient education. 
This study gives population-based insight that it might be possible to 
reduce multimorbidity and thus, the general disease burden at older age 
with smoking cessation, weight reduction, and increased physical ac-
tivity although other determinants of health may also play a role. 
4.1. Conclusion 
In this study we found that Finnish speakers were more multimorbid 
than Swedish speakers, and COPD and diabetes were among diseases 
more common in Finnish speakers. Lifestyle-associated risk factors for 
multimorbidity smoking, overweight, obesity, and physical inactivity 
should be targeted in health interventions. 
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Hyyppä, M.T., Mäki, J., 2001. Individual-level relationships between social capital and 
self-rated health in a bilingual community. Prev. Med. (Baltim) 32 (2), 148–155. 
https://doi.org/10.1006/pmed.2000.0782. 
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